Zantac / Ranitidine (NDMA Cancer) Attorney in Phoenix, Arizona

Zantac Litigation in Phoenix / Maricopa County

Phoenix-area Zantac claimants include a significant concentration of retired individuals who used Zantac for decades during the drug's peak OTC availability (1996–2020). Maricopa County Superior Court handles complex civil litigation including pharmaceutical cases. Arizona applies Daubert under A.R.E. 702. Phoenix-area claimants may benefit from filing in Delaware Superior Court, where Judge Medinilla's docket has allowed Zantac causation experts to proceed. The federal Zantac MDL (No. 2924, S.D. Florida) was largely dismissed in 2022 after Judge Robin Rosenberg excluded plaintiffs' causation experts under Daubert. However, the Delaware Superior Court under Judge Vivian Medinilla continues to actively hear Zantac cases and has allowed causation experts to proceed. Defendants Sanofi, Boehringer Ingelheim, GSK, and Pfizer are all actively litigating in Delaware. For most claimants, filing in Delaware Superior Court through national plaintiffs' counsel is now the primary path forward.

Resources for Phoenix Zantac Cancer Claimants

Phoenix-area Zantac claimants should gather prescription records from Fry's Pharmacy (Kroger), CVS, Walgreens, and Costco — all of which sold ranitidine OTC through April 2020. Arizona's 2-year SOL with the discovery rule means claimants with 2024 cancer diagnoses have active windows; earlier diagnoses require discovery rule analysis regarding when the NDMA-cancer link was or should have been known. Mayo Clinic Arizona is an excellent resource for comprehensive oncology records.